EDGAR Filing Documents for 0001279569-15-002035

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-15-002035

Filing Date

2015-10-28

Accepted

2015-10-28 09:57:18

Documents

Period of Report

2015-10-28

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	transitionthera6k.htm	6-K	10878
2	NEWS RELEASE DATED OCTOBER 28, 2015	ex991.htm	EX-99.1	6444
	Complete submission text file	0001279569-15-002035.txt		18326

Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7

Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770

Transition Therapeutics Inc. (Filer) CIK: 0001399250 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-33514 | Film No.: 151179254
SIC: 2833 Medicinal Chemicals & Botanical Products